{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T06:00:04Z","timestamp":1779256804513,"version":"3.51.4"},"reference-count":34,"publisher":"The Endocrine Society","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,4,1]]},"DOI":"10.1210\/jc.2010-1306","type":"journal-article","created":{"date-parts":[[2011,2,3]],"date-time":"2011-02-03T04:44:34Z","timestamp":1296708274000},"page":"E707-E712","source":"Crossref","is-referenced-by-count":81,"title":["Neonatal Hyperparathyroidism with a Heterozygous Calcium-Sensing Receptor (CASR) R185Q Mutation: Clinical Benefit from Cinacalcet"],"prefix":"10.1210","volume":"96","author":[{"given":"Christina M. S.","family":"Reh","sequence":"first","affiliation":[{"name":"The Center for Endocrinology, Diabetes, and Metabolism at Children's Hospital Los Angeles (C.M.S.R., D.D.J.), Keck School of Medicine of University of Southern California, Los Angeles, California 90027;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geoffrey N.","family":"Hendy","sequence":"additional","affiliation":[{"name":"Departments of Medicine, Physiology, and Human Genetics (G.N.H.), McGill University, and Calcium Research Laboratory and Hormones and Cancer Research Unit, Royal Victoria Hospital, Montr\u00e9al, Qu\u00e9bec, Canada H3A 1A1;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David E. C.","family":"Cole","sequence":"additional","affiliation":[{"name":"Departments of Laboratory Medicine and Pathobiology, Medicine, and Genetics (D.E.C.C.), University of Toronto, Toronto, Ontario, Canada M5G IL5"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debra D.","family":"Jeandron","sequence":"additional","affiliation":[{"name":"The Center for Endocrinology, Diabetes, and Metabolism at Children's Hospital Los Angeles (C.M.S.R., D.D.J.), Keck School of Medicine of University of Southern California, Los Angeles, California 90027;"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","reference":[{"key":"2019041115283296000_B1","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/366575a0","article-title":"Cloning and characterization of an extracellular Ca(2+)-sensing receptor from bovine parathyroid.","volume":"366","author":"Brown","year":"1993","journal-title":"Nature"},{"key":"2019041115283296000_B2","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0889-8529(05)70148-1","article-title":"Familial hypocalciuric hypercalcemia and other disorders with resistance to extracellular calcium.","volume":"29","author":"Brown","year":"2000","journal-title":"Endocrinol Metab Clin North Am"},{"key":"2019041115283296000_B3","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1877-1173(09)89003-0","article-title":"Calcium-sensing receptor and associated diseases.","volume":"89","author":"Hendy","year":"2009","journal-title":"Prog Mol Biol Transl Sci"},{"key":"2019041115283296000_B4","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/(SICI)1096-8628(19970808)71:2<202::AID-AJMG16>3.0.CO;2-I","article-title":"Neonatal severe hyperparathyroidism, secondary hyperparathyroidism, and familial hypocalciuric hypercalcemia: multiple different phenotypes associated with an inactivating Alu insertion mutation of the calcium-sensing receptor (CASR) gene.","volume":"71","author":"Cole","year":"1997","journal-title":"Am J Med Genet"},{"key":"2019041115283296000_B5","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1046\/j.1365-2265.1999.00788.x","article-title":"Casting new light on the clinical spectrum of neonatal severe hyperparathyroidism.","volume":"50","author":"Pearce","year":"1999","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041115283296000_B6","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.siny.2003.10.002","article-title":"Perinatal calcium metabolism: physiology and pathophysiology.","volume":"9","author":"Hsu","year":"2004","journal-title":"Semin Neonatol"},{"key":"2019041115283296000_B7","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S1043-2760(98)00119-2","article-title":"Calcimimetic compounds: a direct approach to controlling plasma levels of parathyroid hormone in hyperparathyroidism.","volume":"10","author":"Nemeth","year":"1999","journal-title":"Trends Endocrinol Metab"},{"key":"2019041115283296000_B8","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1111\/j.1365-2362.2007.01874.x","article-title":"The role of calcimimetics in the treatment of hyperparathyroidism.","volume":"37","author":"W\u00fcthrich","year":"2007","journal-title":"Eur J Clin Invest"},{"key":"2019041115283296000_B9","doi-asserted-by":"crossref","first-page":"4860","DOI":"10.1210\/jc.2009-1472","article-title":"Cinacalcet treatment of primary hyperparathyroidism: biochemical and bone densitometric outcomes in a five-year study.","volume":"94","author":"Peacock","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041115283296000_B10","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1365-2796.2006.01684.x","article-title":"Normalization of serum calcium by cinacalcet in a patient with hypercalcemia due to a de novo inactivating mutation of the calcium-sensing receptor.","volume":"260","author":"Timmers","year":"2006","journal-title":"J Intern Med"},{"key":"2019041115283296000_B11","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1365-2265.2007.03027.x","article-title":"Correction of hypercalcemia by cinacalcet in familial hypocalciuric hypercalcemia.","volume":"68","author":"Festen-Spanjer","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041115283296000_B12","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1677\/JME-08-0164","article-title":"Calcium-sensing receptor (CASR) mutations and denaturing high performance liquid chromatography (DHPLC).","volume":"42","author":"Cole","year":"2009","journal-title":"J Mol Endocrinol"},{"key":"2019041115283296000_B13","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/0092-8674(93)90617-Y","article-title":"Mutations in the human Ca2+-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism.","volume":"75","author":"Pollak","year":"1993","journal-title":"Cell"},{"key":"2019041115283296000_B14","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1172\/JCI118335","article-title":"Calcium-sensing receptor mutations in familial benign hypercalcemia and neonatal hyperparathyroidism.","volume":"96","author":"Pearce","year":"1995","journal-title":"J Clin Invest"},{"key":"2019041115283296000_B15","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1210\/jcem.81.4.8636323","article-title":"Clustered inactivating mutations and benign polymorphisms of the calcium-sensing receptor gene in familial benign hypocalciuric hypercalcemia suggest receptor functional domains.","volume":"81","author":"Heath","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041115283296000_B16","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1172\/JCI119137","article-title":"In vivo and in vitro characterization of neonatal hyperparathyroidism resulting from a de novo, heterozygous mutation in the Ca2+-sensing receptor gene: normal maternal calcium homeostasis as a cause of secondary hyperparathyroidism in familial benign hypocalciuric hypercalcemia.","volume":"99","author":"Bai","year":"1997","journal-title":"J Clin Invest"},{"key":"2019041115283296000_B17","first-page":"337","article-title":"Hypocalciuric hypercalcemia due to a de novo mutation of the calcium-sensing receptor.","volume":"64","author":"Sarli","year":"2004","journal-title":"Medicina (Buenos Aires)"},{"key":"2019041115283296000_B18","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s00431-008-0794-y","article-title":"Unusually severe phenotype of neonatal primary hyperparathyroidism due to a heterozygous inactivating mutation in the CASR gene.","volume":"168","author":"Obermannova","year":"2009","journal-title":"Eur J Pediatr"},{"key":"2019041115283296000_B19","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1021\/bi8014604","article-title":"Multiple Ca2+-binding sites in the extracellular domain of the Ca2+-sensing receptor corresponding to cooperative Ca2+ response.","volume":"48","author":"Huang","year":"2009","journal-title":"Biochemistry"},{"key":"2019041115283296000_B20","doi-asserted-by":"crossref","first-page":"19537","DOI":"10.1074\/jbc.271.32.19537","article-title":"Expression and characterization of inactivating and activating mutations in the human Ca2+o-sensing receptor.","volume":"271","author":"Bai","year":"1996","journal-title":"J Biol Chem"},{"key":"2019041115283296000_B21","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1093\/hmg\/ddl145","article-title":"The calcium-sensing receptor (CASR) dimerizes in the endoplasmic reticulum: biochemical and biophysical characterization of novel CASR mutations causing familial hypocalciuric hypercalcemia.","volume":"15","author":"Pidasheva","year":"2006","journal-title":"Hum Mol Genet"},{"key":"2019041115283296000_B22","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.1073\/pnas.96.6.2834","article-title":"Intermolecular interactions between dimeric calcium-sensing receptor monomers are important for its normal function.","volume":"96","author":"Bai","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041115283296000_B23","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1210\/jc.2004-1791","article-title":"Functional characterization of calcium-sensing receptor codon 227 mutations presenting either as familial (benign) hypocalciuric hypercalcemia or neonatal hyperparathyroidism.","volume":"90","author":"Wystrychowski","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041115283296000_B24","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1210\/jc.2007-0123","article-title":"Identification and functional characterization of a novel mutation in the calcium-sensing receptor gene in familial hypocalciuric hypercalcemia: modulation of clinical severity by vitamin D status.","volume":"92","author":"Zajickova","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041115283296000_B25","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/j.1365-2265.1994.tb02586.x","article-title":"Neonatal primary hyperparathyroidism masked by vitamin D deficiency.","volume":"41","author":"Meeran","year":"1994","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041115283296000_B26","first-page":"921","article-title":"Use of bisphosphonates in children and adolescents.","volume":"15","author":"Allgrove","year":"2002","journal-title":"J Pediatr Endocrinol Metab"},{"key":"2019041115283296000_B27","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00431-004-1491-0","article-title":"Neonatal severe hyperparathyroidism: genotype\/phenotype correlation and the use of pamidronate as rescue therapy.","volume":"163","author":"Waller","year":"2004","journal-title":"Eur J Pediatr"},{"key":"2019041115283296000_B28","doi-asserted-by":"crossref","first-page":"e1350","DOI":"10.1542\/peds.2006-3209","article-title":"Neonatal hyperparathyroidism and pamidronate therapy in an extremely premature infant.","volume":"120","author":"Fox","year":"2007","journal-title":"Pediatrics"},{"key":"2019041115283296000_B29","first-page":"380","article-title":"Use of bisphosphonates in an 8 week old child with a calcium sensing receptor defect","author":"Gensure"},{"key":"2019041115283296000_B30","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1007\/s00467-010-1547-5","article-title":"Beneficial effect of cinacalcet in a child with familial hypocalciuric hypercalcemia.","volume":"25","author":"Alon","year":"2010","journal-title":"Pediatr Nephrol"},{"key":"2019041115283296000_B31","doi-asserted-by":"crossref","first-page":"4797","DOI":"10.1210\/jc.2008-1076","article-title":"Novel inactivating mutations of the calcium-sensing receptor: the calcimimetic NPS R-568 improves signal transduction of mutant receptors.","volume":"93","author":"Rus","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041115283296000_B32","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1124\/jpet.109.159228","article-title":"Effect of the calcimimetic R-568 [3-(2-chlorophenyl)-N-((1R)-1-(3-methoxyphenyl)ethyl)-1-propanamine] on correcting inactivating mutations in the human calcium-sensing receptor.","volume":"331","author":"Lu","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"2019041115283296000_B33","doi-asserted-by":"crossref","first-page":"9517","DOI":"10.1074\/jbc.M609045200","article-title":"Rescue of calcium-sensing receptor mutants by allosteric modulators reveals a conformational checkpoint in receptor biogenesis.","volume":"282","author":"Huang","year":"2007","journal-title":"J Biol Chem"},{"key":"2019041115283296000_B34","article-title":"CDC growth charts: United States advance data from vital and health statistics, no. 314","author":"Kuczmarski","year":"2000"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/96\/4\/E707\/9070103\/jcemE707.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,3]],"date-time":"2024-04-03T20:06:15Z","timestamp":1712174775000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/96\/4\/E707\/2720891"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4,1]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,4,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2010-1306","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,4,1]]}}}